Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients
Open Access
- 27 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (9), 2621-2624
- https://doi.org/10.1093/ndt/gfl201
Abstract
Background. Recent guidelines suggest supplementation with ergocalciferol (vitamin D 2 ) in chronic kidney disease stages 3 and 4 patients with elevated parathyroid hormone (PTH) levels and 25-hydroxyvitamin D (25OHD) levels Methods. Serum 25OHD and PTH concentrations were measured in 419 transplant patients attending a single renal transplant clinic over a 4-month period. Demographic and biochemical data were also collected, including serum creatinine, calcium, phosphate and albumin. Simple and multiple linear regression analysis were performed. Results. In 27.3% of the patients, 25OHD deficiency was present, and 75.5% had insufficiency. On univariate analysis, 25OHD, serum albumin and estimated glomerular filtration rate (eGFR) were significantly associated with PTH levels ( P < 0.0001, P = 0.004 and P < 0.0001, respectively). Multiple linear regression demonstrated that only 25OHD, eGFR and serum phosphate were significantly predictive of PTH levels ( R2 = 0.19, P < 0.0001). In this model, a 75 nmol/l increase in 25OHD will only result in a maximal reduction in PTH of 2.0 pmol/l. Conclusions. We conclude that 25OHD deficiency and insufficiency are common in renal transplant patients and may exacerbate secondary hyperparathyroidism. However, 25OHD, eGFR and phosphate only account for 19% of the variability in PTH levels. In addition, even a large increase in serum 25OHD levels is likely to result in only a small reduction in PTH. Therefore, alternative approaches to managing hyperparathyroidism in renal transplant recipients rather than supplementation with ergocalciferol are warranted.Keywords
This publication has 16 references indexed in Scilit:
- Low Vitamin D and High Parathyroid Hormone Levels as Determinants of Loss of Muscle Strength and Muscle Mass (Sarcopenia): The Longitudinal Aging Study AmsterdamJournal of Clinical Endocrinology & Metabolism, 2003
- Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levelsKidney International, 2003
- Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failureNephrology Dialysis Transplantation, 2002
- Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?Kidney International, 1999
- Ultraviolet B and blood pressureThe Lancet, 1998
- Sequential changes of biochemical bone parameters after kidney transplantation.Nephrology Dialysis Transplantation, 1998
- Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.Journal of Clinical Endocrinology & Metabolism, 1995
- Rapid Loss of Vertebral Mineral Density after Renal TransplantationNew England Journal of Medicine, 1991
- The Effect of 25-Hydroxy Vitamin D3 in the Osteomalacia of Chronic Renal FailureClinical Science, 1977
- 25-hydroxycholecalciferol stimulation of muscle metabolism.JCI Insight, 1975